Sort
40,608 grants matching “prostate cancer”
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1
$972,039Thomas Eling · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
TARGETING HISTONE LYSINE DEMETHYLASE KDM4A IN NEUROENDOCRINE PROSTATE CANCER.
$972,000The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Defense Health Agency
TARGETING DNA REPAIR PATHWAYS IN PROSTATE CANCER
$971,994The University Of Texas Southwestern Medical Center · · FY2017 · Department of the Army
ANALYSIS OF THE GENETIC LANDSCAPE IN THE EVOLUTION OF OLIGOMETASTATIC PROSTATE CANCER THROUGH PERIPHERAL BIOANALYTES.
$971,976The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Defense Health Agency
Discovery Expansion and Replication
$971,947Brian E Henderson · University Of Southern California · U19 · FY2013 · CA
A NEW PARADIGM COUPLING STROMAL MIRCROENVIRONMENT TO PROSTATE CANCER LIPID AND RNA SYNTHESIS WITH THERAPEUTIC APPLICATION
$971,736The Johns Hopkins University · · FY2017 · Department of the Army
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
$971,712Duane T. Smoot · Howard University · U54 · FY2009 · CA
Human PSMA MAb Radioimmunotherapy for Prostate Cancer
$971,397Dangshe Ma · Progenics Pharmaceuticals, Inc. · R44 · FY2007 · CA
NEW AWARD - EFFECTIVE DATE:15 JUN 2020, DATE SIGNED: 10-JUN-2020, DATE DISTRIBUTED: 6/10/2020, FAADC DATE: 6/10/2020...DEVELOPMENT OF 5D3 MAB AND USPIO-BASED THERANOSTICS FOR IMAGE-GUIDED PROSTATE CANCER THERAPY
$971,022The Johns Hopkins University · · FY2020 · Defense Health Agency
Identification of key players mediating internalization of Trichomonas vaginalis extracellular vesicles by host cells and parasite adherence and survival in vivo
$970,686Patricia Jean Johnson · University Of California Los Angeles · R01 · FY2024 · AI
Shanghai Men's Health Study
$970,385Xiao-Ou Shu · Vanderbilt University · UM1 · FY2013 · CA
Biological Functions of Chromosomal Proteins
$969,817Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Administrative Core
$969,641Shafiq A Khan · Clark Atlanta University · U54 · FY2022 · MD
Biospecimen procurement and tissue microarray manufacture for the CHTN
$969,371Christopher A. Moskaluk · University Of Virginia · UM1 · FY2023 · CA
Targeting Castration Resistant Prostate Cancer via Potent Inhibition of Signaling Lipids
$969,204Salma Kaochar · Baylor College Of Medicine · R01 · FY2025 · CA
Understanding and Addressing Cancer Health Disparities in Louisiana
$968,492Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2020 · CA
DEFINING THE POTENTIAL OF EARLY MOLECULAR SUBTYPES OF PROSTATE CANCER TO PROGRESS TO AR-INDIFFERENT DISEASE
$968,381Weill Medical College Of Cornell University · · FY2019 · Defense Health Agency
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$968,200Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
CANCER AND INFLAMMATION GENETICS
$968,200Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern
$968,153Martin G Sanda · Emory University · U01 · FY2024 · CA
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
$967,979Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2022 · CA
TARGETING THE SUBTYPE OF METASTATIC PROSTATE CANCER DEFICIENT IN DNA REPAIR CAPACITY
$967,893University Of Washington · · FY2018 · Department of the Army
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$967,866Andrea Califano · Columbia University Health Sciences · U01 · FY2025 · CA
INVESTIGATING THE GENOMIC EVOLUTION OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
$967,500Regents Of The University Of California, San Francisco, The · · FY2019 · Department of the Army
Biostatistics Resource
$967,148Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2009 · CA